ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 3 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $823,000 | -35.2% | 205 | -25.7% | 0.08% | -56.8% |
| Q4 2018 | $1,270,000 | -59.1% | 276 | -60.6% | 0.18% | -39.7% |
| Q3 2018 | $3,107,000 | +87.4% | 700 | +65.5% | 0.31% | +113.2% |
| Q2 2018 | $1,658,000 | +21.3% | 423 | +123.8% | 0.14% | -11.1% |
| Q1 2018 | $1,367,000 | – | 189 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 12,106 | $87,562,000 | 5.23% |
| Iguana Healthcare Management, LLC | 50,000 | $3,617,000 | 2.38% |
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $1,367,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 37,900 | $2,741,000 | 0.03% |
| SIMPLEX TRADING, LLC | 259 | $110,000 | 0.01% |